Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12.62 USD | +0.08% | -0.24% | +3.95% |
05-14 | Centogene, Evotec Discover New Molecule for Potential Gaucher Disease Treatment | MT |
04-30 | Evotec, Bayer to Collaborate on New Cardiovascular Disease Therapies | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+3.95% | 0 | |
+12.07% | 9.59B | |
-0.13% | 5.58B | |
+8.74% | 5.5B | |
+6.77% | 5.24B | |
+28.16% | 4.84B | |
+23.14% | 4.61B | |
+2.73% | 4.13B | |
+7.31% | 4.05B | |
-0.11% | 3.28B |
- Stock Market
- Equities
- EVO Stock
- News Eaton Vance Ohio Municipal Income Trust
- Morgan Stanley Upgrades Evotec to Overweight From Equal Weight, Adjusts Price Target to $16 From $12